As an aggressive subtype of breast cancers, triple-negative breast cancer (TNBC) are defined by the lack of estrogen receptor (ER) and progesterone receptor (PR) and absence of human epidermal growth factor receptor 2 (HER2) protein overexpression and HER2 gene amplification7. This evidence concerns the gene ERBB2 and breast cancer.